BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 37938933)

  • 1. Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
    Zhan J; Wang J; Zhang Z; Xue R; Jiang S; Liu J; Liu Y; Zhu L; Xia J; Yan X; Ding W; Zhu C; Qiu Y; Li J; Huang R; Wu C
    Virulence; 2023 Dec; 14(1):2268497. PubMed ID: 37938933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 3. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of liver stiffness measurement based nomograms to the assessments of hepatitis B related significant fibrosis and cirrhosis.
    Ji SS; Jiang HD; Jiang JC; Li J; Lin ST; Chen B; Xu SH
    Clin Chim Acta; 2019 Feb; 489():75-82. PubMed ID: 30471249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
    Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
    Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Nomogram to Predict Significant Liver Inflammation in Patients with Chronic Hepatitis B.
    Jiang S; Wang J; Zhang Z; Zhan J; Xue R; Qiu Y; Zhu L; Zhang S; Pan Y; Yan X; Chen Y; Li J; Liu X; Zhu C; Huang R; Wu C
    Infect Drug Resist; 2023; 16():5065-5075. PubMed ID: 37576516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
    World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
    Wang J; Xia J; Yan X; Yang Y; Wei J; Xiong Y; Wu W; Liu Y; Chen Y; Jia B; Chen Z; Zhang Z; Ding W; Huang R; Wu C
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):913-922. PubMed ID: 32147439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.
    Luo J; Du Z; Liang D; Li M; Yin Y; Chen M; Yang L
    J Clin Lab Anal; 2022 Aug; 36(8):e24596. PubMed ID: 35808928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B.
    Chen Y; Gong J; Zhou W; Jie Y; Li Z; Chong Y; Hu B
    Biomed Res Int; 2020; 2020():6839137. PubMed ID: 32695818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal.
    Chen S; Huang H; Huang W
    BMC Gastroenterol; 2021 Jan; 21(1):4. PubMed ID: 33407146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study.
    Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY
    Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W; Li Y; Geng J; Wang P; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
    Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
    Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection.
    Chang X; Wang J; Chen Y; Long Q; Song L; Li Q; Liu H; Shang Q; Yu Z; Jiang L; Xiao G; Li L; Chen L; Wang X; Li Z; Chen D; Dong Z; An L; Tan L; Chen Y; Yang Y
    EBioMedicine; 2021 May; 67():103389. PubMed ID: 34004423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
    Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.